[
    [
        {
            "time": "2023-01-01",
            "original_text": "Regeneron Expands Agreement to Develop Coronavirus Therapy",
            "features": {
                "keywords": [
                    "Regeneron",
                    "Expands",
                    "Agreement",
                    "Develop",
                    "Coronavirus",
                    "Therapy"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Regeneron Expands Agreement to Develop Coronavirus Therapy",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-01-01",
            "original_text": "Can Humira/Cancer Drugs Help AbbVie (ABBV) Beat Q4 Earnings?",
            "features": {
                "keywords": [
                    "Humira",
                    "Cancer",
                    "Drugs",
                    "Help",
                    "AbbVie",
                    "Beat",
                    "Q4",
                    "Earnings"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Can Humira/Cancer Drugs Help AbbVie (ABBV) Beat Q4 Earnings?",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-01-01",
            "original_text": "FORM 8.3 - ABBVIE INC - Amendment",
            "features": {
                "keywords": [
                    "FORM",
                    "8.3",
                    "ABBVIE",
                    "INC",
                    "Amendment"
                ],
                "sentiment_score": 0.0,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "FORM 8.3 - ABBVIE INC - Amendment",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 4,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-01-01",
            "original_text": "RINVOQ™ (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Study in Psoriatic Arthritis",
            "features": {
                "keywords": [
                    "RINVOQ",
                    "upadacitinib",
                    "Meets",
                    "Primary",
                    "Secondary",
                    "Endpoints",
                    "Phase",
                    "3",
                    "Study",
                    "Psoriatic",
                    "Arthritis"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "RINVOQ™ (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Study in Psoriatic Arthritis",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-01-01",
            "original_text": "AbbVie Stock Rises 3%",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Stock",
                    "Rises",
                    "3%"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AbbVie Stock Rises 3%",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 7,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-01-01",
            "original_text": "Form 8.3 - ABBVIE INC",
            "features": {
                "keywords": [
                    "Form",
                    "8.3",
                    "ABBVIE",
                    "INC"
                ],
                "sentiment_score": 0.0,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Form 8.3 - ABBVIE INC",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 4,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-01-01",
            "original_text": "FORM 8.3 - ABBVIE INC AMENDMENT",
            "features": {
                "keywords": [
                    "FORM",
                    "8.3",
                    "ABBVIE",
                    "INC",
                    "AMENDMENT"
                ],
                "sentiment_score": 0.0,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "FORM 8.3 - ABBVIE INC AMENDMENT",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 4,
                "Source_Recency": 6
            }
        }
    ]
]